Charles River Laboratories Hits Day Low of $151.91 Amid Price Pressure

Charles River Laboratories International, Inc. experienced significant volatility on March 12, 2026, with the stock declining by 9.62% and reaching an intraday low of USD 151.91. This performance starkly contrasts with the S&P 500, which fell by only 1.52% on the same day. Over the past week, Charles River's stock has dropped 15.81%, while its one-month performance shows a decrease of 3.83%. In the broader context, the company has underperformed the market over the past year, with a return of just 0.45% compared to the S&P 500's 19.17%. Year-to-date, the stock is down 23.47%, and its three-year performance reflects a decline of 24.63%. Financial metrics indicate a challenging environment for Charles River Laboratories, with a return on capital employed (ROCE) averaging 11.49%. The company reported a net profit of USD 118.7 million for the first half of the year, marking a decline of 37.49%. Additionally, raw material costs have increased by 5.87% year-over-year, contributing to the stock's current performance challenges.